| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/31/2005 | CN1660047A Dermatological formulation containing 8-hexadecen-1, 16-dicarboxylic |
| 08/31/2005 | CN1216869C Polymorphic crystalline forms of celecoxib |
| 08/31/2005 | CN1216859C Comminuted form of (S)-2-ethoxy-3-[4-(2-{4-methane-sulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
| 08/31/2005 | CN1216676C Chemical method for making pyrithione particle dispersions |
| 08/31/2005 | CN1216648C Vapour dispensing device |
| 08/31/2005 | CN1216643C Edible holographic products particularly pharmaceuticals and methods and apparatus for producing same |
| 08/31/2005 | CN1216642C Anti-infective active substance combinations and use thereof for topical treatment of fungus diseases of toe and finger nails |
| 08/31/2005 | CN1216636C Titanium slow-release composition |
| 08/31/2005 | CN1216635C Composition and method for curing diabetes |
| 08/31/2005 | CN1216631C Blood quickening statis transforming plaster |
| 08/31/2005 | CN1216619C Plaster for treating facial paralysis |
| 08/31/2005 | CN1216618C A TCM compound recipe notoginseng capsule and method for preparing the same |
| 08/31/2005 | CN1216615C Plaster for treating rheumatic diseases and psoatic strain and its prepn process |
| 08/31/2005 | CN1216608C Rifaximin soft capsule composition |
| 08/31/2005 | CN1216606C Stable aspirin ointment preparations |
| 08/31/2005 | CN1216603C Nitroimiazoles colon target medicine and its preparing process |
| 08/31/2005 | CN1216601C Crataegus leaf flarone powder injection for treating heart and brain blood vessel disease and its preparation method |
| 08/31/2005 | CN1216600C Levo-salbutamol hydrochloride aerosol and its prepn. |
| 08/31/2005 | CN1216597C Floating type pulse release capsule in stomach |
| 08/31/2005 | CN1216596C Acrylic enteric coating compsns. |
| 08/31/2005 | CN1216595C Novel preparation for local use |
| 08/31/2005 | CN1216594C Suspension comprising oxcarbazepine |
| 08/31/2005 | CN1216593C Liquid wound plaster and its preparing method |
| 08/30/2005 | US6936661 Medical contact adhesive comprising a two phase adhesive matrix of polyacrylates and polyamine salts |
| 08/30/2005 | US6936635 Composition for the treatment of respiratory disorders and a method for its use |
| 08/30/2005 | US6936628 Orally administering one or more pharmaceutically acceptable acid neutralizing buffers with epothiolones (simultaneously, before or after) to increase the vioavailability of epothiolones |
| 08/30/2005 | US6936605 Pharmaceutical composition |
| 08/30/2005 | US6936596 Adenosine derivatives and use thereof |
| 08/30/2005 | US6936589 Concurrent administering of druh and hypotonic sugar solution |
| 08/30/2005 | US6936588 homogenizing water, fat, a nitrogen-containing component, and carbohydrate with the inclusion of isomaltulose, pasteurizing for 10-30 seconds at 135 degrees c and sterilizing |
| 08/30/2005 | US6936282 Composition of traditional chinese medicines for preventing and treating cerebrovascular disease |
| 08/30/2005 | US6936280 Method for preparing a composition by extraction of mother-of-pearl, composition obtained by said method and use thereof in cosmetics and dermatology |
| 08/30/2005 | US6936279 Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations |
| 08/30/2005 | US6936278 Microparticles |
| 08/30/2005 | US6936277 Forming an aqueous slurry containing a mixture of microcrystalline cellulose in the form of a wet cake and an ionic surfactant, drying the slurry to obtain an excipient |
| 08/30/2005 | US6936276 For tissue regeneration, applying a multilayer biodegradable matrix of crosslinked proteins and/or polysaccharides, where each layer has porosity to accomodate living cells; bone, joint, cartilage repair |
| 08/30/2005 | US6936275 Controlled release of drugs from a monolithic tablet for oral delivery containing granules of a drug, granulated with an amino acid, and an intragranular polymer, the granules are then dispersed within hydrophilic extragranular polymer |
| 08/30/2005 | US6936274 Storage stable thyroxine active drug formulations and methods for their production |
| 08/30/2005 | US6936273 Treating lameness in horses with a topical nonsteroidal antiinflammatory formulation of diclofenac salt, propylene glycol, ethanol, vitamin E acetate, phospholipid, wherein vesicles or liposomes of the diclofenac salt are present |
| 08/30/2005 | US6936272 10139483Therapeutic liposome composition and method of preparation |
| 08/30/2005 | US6936270 Orthopedic hardware with a sustained release device configured to release a compound over an extended period of time and is attachable to a portion of the body |
| 08/30/2005 | US6936268 Where the quantity of heat required for the evaporation of water is adjusted to a predetermined level, for a refreshing user feel; cosmetic applications for skin adjustment and beauty; contains a polyalkylene glycol, gelatin and/or polyacrylic acid |
| 08/30/2005 | US6936250 Polysaccharide encapsualted antigen |
| 08/30/2005 | US6936244 Bacterial infection of the eye can be treated with lytic enzyme produced by bacteria being infected with bacteriophage specific for that bacteria |
| 08/30/2005 | US6936187 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use |
| 08/30/2005 | US6936029 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 08/30/2005 | US6935271 Method for producing a bovine teat dip |
| 08/30/2005 | CA2330207C Microneedle devices and methods of manufacture and use thereof |
| 08/30/2005 | CA2213774C Pharmaceutical compositions and devices for their administration |
| 08/30/2005 | CA2211262C Micellar nanoparticles |
| 08/30/2005 | CA2186038C A topical dressing, method of manufacturing a topical dressing and use of a topical dressing |
| 08/30/2005 | CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/30/2005 | CA2103667C Liquid compositions based on 1,4 substituted piperidine derivatives |
| 08/27/2005 | CA2491203A1 Topical antibacterial formulations |
| 08/26/2005 | WO2004073033A2 Material incapsulation system |
| 08/26/2005 | CA2553699A1 Material incapsulation system |
| 08/25/2005 | WO2005077513A1 Mixture comprising a detergent and a co-detergent |
| 08/25/2005 | WO2005077450A2 Intravascular delivery system for therapeutic agents |
| 08/25/2005 | WO2005077420A1 Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same |
| 08/25/2005 | WO2005077419A1 Soft capsule preparation |
| 08/25/2005 | WO2005077414A1 Highly concentrated liquid formulations of anti-egfr antibodies |
| 08/25/2005 | WO2005077402A1 Honey based gel formulations |
| 08/25/2005 | WO2005077387A1 Spermicidal preparations and uses thereof |
| 08/25/2005 | WO2005077379A1 Remedy for external use for skin and mucosal injuries caused by viral infection |
| 08/25/2005 | WO2005077376A1 A stable parental formulation of levomepromazine and a method for stabilizing said formulation |
| 08/25/2005 | WO2005077374A1 Formulations of phosphodiesterase 5 inhibitors and methods of use |
| 08/25/2005 | WO2005077364A1 Transdermal solifenacin preparation and method of improving transdermal permeability thereof |
| 08/25/2005 | WO2005077357A1 Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
| 08/25/2005 | WO2005077349A1 HUMAN β-DEFENSIN PRODUCTION ACCELERATOR |
| 08/25/2005 | WO2005077346A1 Controlled release formulations |
| 08/25/2005 | WO2005077342A1 Enterically coated lansoprazole microtablets |
| 08/25/2005 | WO2005077341A1 Orally disintegrating pharmaceutical compositions of ondansetron |
| 08/25/2005 | WO2005077340A1 Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
| 08/25/2005 | WO2005077339A1 Process for preparing stable sol of pharmaceutical ingredients and hydrofluorocarbon comprising milling the said sol, then transfert it into a canister |
| 08/25/2005 | WO2005077338A1 Particles for inhalation rapid release properties |
| 08/25/2005 | WO2005077337A2 Dispersions prepared by use of self-stabilizing agents |
| 08/25/2005 | WO2005077336A1 Composition and formulation of colloidal system comprising biocompatible aqueous-soluble polymer, and preparation method thereof |
| 08/25/2005 | WO2005077335A1 Intravenous solution producing systems and methods |
| 08/25/2005 | WO2005077334A1 Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir |
| 08/25/2005 | WO2005077332A2 Stable sustained-release oral dosage forms of gabapentin and process for preparation thereof |
| 08/25/2005 | WO2005077331A1 Chronotherapeutic compositions and methods of their use |
| 08/25/2005 | WO2005077330A1 Electromagnetic radiation addressable materials |
| 08/25/2005 | WO2005077304A1 Load bearing biocompatible device |
| 08/25/2005 | WO2005077013A2 Surface directed cellular attachment |
| 08/25/2005 | WO2005076987A2 Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
| 08/25/2005 | WO2005076829A2 Stable loratadine spill resistant formulation |
| 08/25/2005 | WO2005076697A2 Cosmetic and pharmaceutical foam with solid matter |
| 08/25/2005 | WO2005063225A8 Compositions and methods for treating hepatitis c virus (hcv) infection |
| 08/25/2005 | WO2005055945A3 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 08/25/2005 | WO2005051871A8 Implantable sensors and implantable pumps and anti-scarring agents |
| 08/25/2005 | WO2005051346A3 Compositions comprising organic compounds |
| 08/25/2005 | WO2005046727A3 Ibuprofen-containing soft gelatin capsules |
| 08/25/2005 | WO2005042055A3 Transdermal drug delivery device |
| 08/25/2005 | WO2005020929A3 Sustained release dosage forms of ziprasidone |
| 08/25/2005 | WO2005016410A3 Pharmaceutical metered dose inhaler and methods relating thereto |
| 08/25/2005 | WO2005016306A3 Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation |
| 08/25/2005 | WO2005007108A3 Asymmetric disulfides and methods of using same |
| 08/25/2005 | WO2004112749A3 Ergonomic pointing device |
| 08/25/2005 | WO2004098513A3 Nasal administration of the lh-rh analog leuprolide |
| 08/25/2005 | WO2004066982A8 Stable oral benzimidazole compositions and processes for their preparation |